Glaxo’s ViiV Healthcare tussles with Kazakhstan over an AIDS drug

July 5, 2019 |
The Growing Toll of the Global Gag Rule
High price delays introduction of new TB prevention therapy
Related Posts
Access to Medicines

Pfizer and BioNTech Profit...
Funding the Fight

Now more than ever, countr...
Access to Medicines

Biden Can’t Correct ...